Status:
ACTIVE_NOT_RECRUITING
Improving Cardiac Secondary Prevention
Lead Sponsor:
Western University, Canada
Conditions:
Myocardial Infarction
Secondary Prevention
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether providing individuals with personalized information on cellular aging, including telomere length, will stimulate them to adhere to cardiac prevention ...
Detailed Description
Individuals who have sustained a heart attack are at considerable risk for future cardiac events. A cardiac rehabilitation and exercise program can reduce this risk but it remains a challenge to adopt...
Eligibility Criteria
Inclusion
- 1\. Individuals who have sustained a myocardial infarction and entered the cardiac rehabilitation program
Exclusion
- Individuals with genetic mutations that affect telomere length
- Individuals who may not have the mental capacity to understanding the ramifications of risk biomarkers
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03269708
Start Date
March 1 2019
End Date
September 1 2024
Last Update
May 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre, Western University
London, Ontario, Canada, N6A 5A5